Form 4: Roivant Sciences CEO Matthew Gline Reports Share Disposal for Tax Obligations
SEC Form 4 Filing
Roivant Sciences CEO Matthew Gline disposed of 10,945 common shares on June 20, 2024, to cover tax withholding obligations related to vested RSUs.
Summary
- On June 20, 2024, Matthew Gline, CEO of Roivant Sciences Ltd., disposed of 10,945 common shares.
- The transaction was executed to cover tax withholding obligations associated with the vesting and settlement of previously granted Restricted Stock Units (RSUs).
- The shares were disposed of at a price of $10.8.
- Following the transaction, Gline directly owns 1,131,816 common shares.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard practice for company insiders, like CEOs, to report transactions in their company's stock, providing transparency to investors.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine disposal of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 06/20/2024 | Date of the transaction where shares were disposed of to cover tax obligations. |
| 06/24/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.